Co-Diagnostics, Inc. CODX
0.13 USD -0.04 (-21.32%)
Regular-session close
0.14 +0.01 +5.95%
After hours · Nov 20, 7:41 PM ET
0.1276 Day range 0.1421
0.1295 52-week range 11.61
- YTD
- -97.45%
- 1 year
- -98.66%
News
benzinga.com Why Gap Shares Are Trading Higher By Around 4%; Here Are 20 Stocks Moving Premarket Gap shares rise 3.8% after Q3 EPS beat estimates; Athleta names new CEO. Erayak and NewGenIvf lead gainers, Solmate leads losers.
prnewswire.com Co-Diagnostics Announces Reverse Stock Split SALT LAKE CITY, Nov. 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Diagnostics" or "the Company"), a molecular diagnostics company with a unique, patented platform for the…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session Gainers SELLAS Life Sciences Gr (NASDAQ:SLS) shares rose 169.8% to $20.16 during Tuesday's regular session. The market value of their outstanding shares is at $1.5 billion. As per the press release,…
prnewswire.com Co-Diagnostics Receives Logix Smart® ZDC Test Order from Peru Distributor as Dengue Cases Rise and Exhibits at MEDICA 2026 in Düsseldorf Company Also Ships Logix Smart ZDC Tests for Study in Bolivia Co-Dx to Meet with International Customers and Distributors at World Trade Center Utah Booth SALT LAKE CITY, Nov. 17, 2026 /PRNewswire/…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 74.0% to $5.03 during Thursday's pre-market session. ZeroStack (NASDAQ:ZSTK) stock increased by 11.56% to $2.99. The market value of their…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Can Fite Biopharma (AMEX:CANF) stock rose 7.1% to $1.66 during Wednesday's after-market session. The market value of their outstanding shares is at $3.5 million. iTonic Holdings (NASDAQ:ITOC)…benzinga.com Co-Diagnostics Q3 EPS $(1.01) Beats $(1.25) Estimate, Sales $282.881K Beat $169.000K Estimate Co-Diagnostics (OTC:CODX) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.25) by 19.2 percent. This is a 78.96 percent increase over losses of $(4.80)…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings…benzinga.com Co-Diagnostics Announces Publication Of Peer-Reviewed Study Using SARAGENE Human Papillomavirus High Risk Test Manufactured By CoSara Diagnostics Follow-Up Biopsies Identified High-Grade Lesions or Cervical Cancer in 12 of 20 HPV-Positive Women, Including a Cohort with Predominantly Negative Cytology ResultsCoSara to Exhibit at MICROCON 2026,…
benzinga.com Co-Diagnostics Moves Closer to Commercial Tuberculosis Test Launch in India Co-Diagnostics filed for Indian clearance for its rapid TB test following successful trials, targeting commercial sales before the year-end.benzinga.com Co-Diagnostics's India JV CoSara Diagnostics Completes Its Clinical Performance Study Of The CoSara PCR Mycobacterium Tuberculosis Test On CoSara PCR Pro Instrument; Has Submitted Test To India's Central Drugs Standard Control Organization For Regulatory Clearance The submission follows the Company's July 22, 2026 announcement that CoSara had initiated clinical studies for the CoSara PCR MTB test across select laboratories in India. The clinical study assessed…
